Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.235
+0.135 (6.43%)
Apr 30, 2026, 2:42 PM EDT - Market open
Grace Therapeutics Employees
Grace Therapeutics had 6 employees as of March 31, 2025. The number of employees increased by 2 or 50.00% compared to the previous year.
Employees
6
Change (1Y)
2
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$996,500
Market Cap
34.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 6 | 2 | 50.00% |
| Mar 31, 2024 | 4 | -28 | -87.50% |
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | 11 | 4 | 57.14% |
| Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| NextCure | 40 |
| Senti Biosciences | 34 |
| Palatin Technologies | 29 |
| Boundless Bio | 28 |
| Daré Bioscience | 24 |
GRCE News
- 6 days ago - Grace Therapeutics Stock Falls As FDA Declines To Approve Brain Hemorrhage Drug - Benzinga
- 7 days ago - US FDA declines to approve Grace Therapeutics' drug for a type of stroke - Reuters
- 7 days ago - Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 - GlobeNewsWire
- 16 days ago - Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 - GlobeNewsWire
- 6 weeks ago - Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences - GlobeNewsWire
- 2 months ago - Grace Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - GlobeNewsWire